CD8A and cancer: Most cancers harbored a longer survival with a high amount of CD8+ T cells [24], while increased expression of protumor cells such as regulatory T cells, tumor associated macrophages, tumor associated neutrophils, and myeloid derived suppressor cells usually portend worse outcome [25].